⌘K

Login Start Free

Home/Filings/4/0001140361-14-045546

4//SEC Filing

CYTRX CORP 4

Accession 0001140361-14-045546

$LADXCIK 0000799698operating

View on SEC.gov Company Profile

Filed

Dec 16, 7:00 PM ET

Accepted

Dec 17, 11:18 AM ET

Size

5.3 KB

Accession

0001140361-14-045546

Insider Transaction Report

Form 4

Period: 2014-12-15

Wieland Douglas Scott

Sr. VP - Drug Development

Transactions

Award
Stock Option (right to buy)
2014-12-15+200,000→ 200,000 total
Exercise: $2.15Exp: 2024-12-14→ CytRx common stock (200,000 underlying)

Footnotes (1)

[F1]The Stock Option vests monthly for 36 months in equal installments, beginning January 15, 2015, provided Reporting Person remains in continuous employ of Issuer.

Documents

1 file

4
doc1.xmlPrimary
FORM 4

Issuer

CYTRX CORP

CIK 0000799698

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0000799698

Filing Metadata

Form type: 4
Filed: Dec 16, 7:00 PM ET
Accepted: Dec 17, 11:18 AM ET
Size: 5.3 KB

View on SEC.gov